Global Insights, Analytics, and Forecasting Lead, CVRM Early Assets and Business Development

Location: Barcelona - Spain (3 days working from the office and 2 days working from home) At AstraZeneca, we're not afraid to do things differently. We're resetting expectations of what a bio-pharmaceutical company can be. This means we're establishing new ways to work, with ground-breaking and cutting-edge methods , and bringing unexpected teams togethe r. The BioPharmaceuticals unit (BBU) of AstraZeneca focuses on development and commercialization of AstraZeneca’s Respiratory, Immunology, Cardiovascular, Metabolic, Renal, and Infectious Disease therapeutic areas. Global Insights and Business Excellence ( GIBE x ) is a strategic function critical for enabling success in the growth of the BBU business. Our ambition is to build an industry-leading organization, empowering our Commercial teams through the generation of compelling evidence and insights, while ensuring they have the tools and skills to deliver impactful launches that change the practice of medicine for the benefit of patients. Within G IBE x , the Insights , Analytics , and Forecasting (IA&F) function supports both the US and Global organizations and is structured by therapy area: Respiratory & Immunology IA&F , and CVRM (Cardiovascular, Renal, Metabolic) IA&F. Team Overview The Global CVRM IA&F Early Assets and Business Development team serves as a strategic business partner to the CVRM Early Commercial & Strategy group and the R&D Global Product Teams, providing market insights that drive key commercial investment decisions and therapeutic area strategy development. Together we strive to uncover deep customer insights to drive improved decision-making and business impact. We are looking for leaders who have the passion to drive business results and bring innovation to what we do for greater impact. Job Description The CVRM IA&F Early Assets and Business Development Lead is expected to provide leadership and strategic direction to deliver competitive advantage s through the application of end - to - end insight s, analytics, and forecast s across the Global market s to support AstraZeneca’s industry-leading CVRM pipeline. Our mission as a team is to improve the quality of the company’s investment decisions to support corporate growth targets . To achieve this, the CVRM Early Assets IA&F t eam is tasked with delivering excellence in market research , customer and competitor insights , data analytics , and forecasting. In addition to strong analytical and forecasting skills, the CVRM Early Assets and Business Development Lead should have excellent communication skills with a demonstrated track record of effective business partnership as demonstrated by material business impact and influencing. This position may be required to manage contractors and consultants to complete projects, but will have no direct reports. The candidate will also be required to continuously evaluate new quantitative analy tics methods , technologies , and datasets. This role works closely with CVRM Early Commercial & Strategy, Medical, Epidemiology, HEOR , Market Access and Pricing , Clinical R&D , Finance, and other senior business partners throughout the organisation. Key Responsibilities: Serve as commercial subject matter expert in established and emerging disease areas of interest to the CVRM Early Commercial and Strategy team. Summarize and present findings through various communication channels; be able to “tell the story ” to senior commercial and R&D stakeholders Construct credibly bold and ambitious patient-based forecast models in Excel that leverage data and insights synthesized from a variety of primary and secondary sources , and benchmarked against internal and external analogs Responsible for commissioning and managing primary research i n a way that enables actionable opportunity/strategy recommendations and informs business case generation Instill and reinforce a culture of continuous innovation, improvement, learning, testing, and deployment of new capabilities for the business Access and evaluate appropriate information using a variety of internal and external tools and data sources Monitor the external environment to stay up to date on leading analytics and forecasting capabilities, both within and outside of pharma, which can be applied within the organization Utilize electronic medical records and medical claims to estimate market sizes for business development opportunities or internal pipeline assets facing milestone investment decisions <s